Open access
Open access
Powered by Google Translator Translator

Secondary analysis of a RCT | Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk.

11 Jul, 2022 | 12:06h | UTC

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis – European Heart Journal

Commentaries:

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity – CardiovascularNews

One-Month DAPT Enough for Complex PCI if Bleeding Risk High – Medscape (free registration required)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.